Performance of SAN Sanofi SA | 5.9% in 12m
Compare SAN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Sanofi SA with its related Sector/Index XLV
Performance Duell SAN vs XLV
TimeFrame | SAN | XLV |
---|---|---|
1 Week | 3.30% | -2.07% |
1 Month | 12.0% | 4.37% |
3 Months | 14.9% | 5.66% |
6 Months | 25.0% | 6.23% |
12 Months | 5.91% | 17.65% |
YTD | 19.8% | 11.77% |
Rel. Perf. 1m | 0.48 | |
Rel. Perf. 3m | 1.09 | |
Rel. Perf. 6m | 1.50 | |
Rel. Perf. 12m | 1.50 | |
Spearman 1m | 0.98 | 0.82 |
Spearman 3m | 0.97 | 0.89 |
Is Sanofi SA a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Sanofi SA (PA:SAN) is currently (September 2024)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.91 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SAN as of September 2024 is 106.15. This means that SAN is currently overvalued and has a potential downside of 1.54% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SAN as of September 2024 is 106.15. This means that SAN is currently overvalued and has a potential downside of 1.54% (Sold with Premium).
Is SAN a buy, sell or hold?
Sanofi SA has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of 5.91%.
In compare to Health Care Sector SPDR Fund, SAN made -11.74% less over the last 12 months. Due to the underperformance, it is recommend to sell SAN.
In compare to Health Care Sector SPDR Fund, SAN made -11.74% less over the last 12 months. Due to the underperformance, it is recommend to sell SAN.
Values above 0%: SAN is performing better - Values below 0%: SAN is underperforming
Compare SAN with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 7.44% | 8.47% | 18.30% | -16.27% |
US NASDAQ 100 | QQQ | 9.09% | 9.88% | 22.43% | -13.94% |
US Dow Jones Industrial 30 | DIA | 6.12% | 8.16% | 19.68% | -12.59% |
German DAX 40 | DBXD | 6.54% | 6.56% | 22.15% | -8.69% |
UK FTSE 100 | ISFU | 5.55% | 5.69% | 12.66% | -12.25% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.98% | 14.27% | 31.25% | 16.82% |
Hongkong Hang Seng | HSI | 5.52% | 7.19% | 24.47% | 11.75% |
Japan Nikkei 225 | EXX7 | 10.42% | 6.28% | 35.11% | 0.05% |
India NIFTY 50 | INDA | 5.40% | 9.35% | 16.54% | -18.40% |
Brasil Bovespa | EWZ | 5.01% | 5.08% | 33.49% | 5.67% |
SAN Sanofi SA vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 7.37% | 11.37% | 17.61% | -18.61% |
Consumer Discretionary | XLY | 5.82% | 6.57% | 22.99% | -0.18% |
Consumer Staples | XLP | 2.72% | 5.89% | 13.16% | -12.24% |
Energy | XLE | 9.07% | 13.08% | 24.66% | 8.05% |
Financial | XLF | 6.47% | 5.24% | 15.08% | -24.83% |
Health Care | XLV | 5.37% | 7.59% | 18.75% | -11.74% |
Industrial | XLI | 7.54% | 8.81% | 20.77% | -15.16% |
Materials | XLB | 7.96% | 10.37% | 22.88% | -5.74% |
Real Estate | XLRE | 3.12% | 6.95% | 13.21% | -17.46% |
Technology | XLK | 10.75% | 10.30% | 26.23% | -12.41% |
Utilities | XLU | 3.80% | 7.79% | 2.86% | -17.85% |
Aerospace & Defense | XAR | 8.51% | 7.96% | 20.51% | -20.43% |
Biotech | XBI | 7.98% | 9.76% | 28.46% | -16.70% |
Homebuilder | XHB | 7.70% | 8.54% | 17.14% | -31.69% |
Retail | XRT | 8.28% | 12.47% | 28.23% | -12.74% |
Does Sanofi SA outperform its market, is SAN a Sector Leader?
No, over the last 12 months Sanofi SA (SAN) made 5.91%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.65%.
Over the last 3 months SAN made 14.87%, while XLV made 5.66%.
No, over the last 12 months Sanofi SA (SAN) made 5.91%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 17.65%.
Over the last 3 months SAN made 14.87%, while XLV made 5.66%.
Period | SAN | XLV | S&P 500 |
---|---|---|---|
1 Month | 11.96% | 4.37% | 3.49% |
3 Months | 14.87% | 5.66% | 1.39% |
12 Months | 5.91% | 17.65% | 22.18% |